NCT00510211已完成不适用
An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,131
- 试验地点
- 1
研究概览
简要总结
The primary objective of this study is to assess the proportion of schizophrenic patients and the proportion of bipolar patients who discontinue olanzapine within 12 months of treatment in outpatient, ambulatory or community settings
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients suffering from schizophrenic or schizoaffective disorders based on the disease diagnostic criteria DSM IV and being prescribed olanzapine during the 45 preceding days.
- •patients suffering from bipolar disorders based on the disease diagnostic criteria DSM IV and being prescribed olanzapine during the 45 preceding days for one of the following:
- •moderate or severe manic episode
- •relapse prevention in patients with bipolar disorder
排除标准
- •current treatment with any investigational drug or procedure at entry or during the whole study
- •hypersensitivity to olanzapine
- •patients with known narrow angle glaucoma risk
研究组 & 干预措施
olanzapine coated tablet
干预措施: olanzapine (Drug)
olanzapine orodispersable tablet
干预措施: olanzapine (Drug)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible TabletSchizophreniaNCT00324051Eli Lilly and Company284
已完成
4 期
Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)SchizophreniaBipolar DisorderSchizoaffective DisorderNCT00303602Eli Lilly and Company149
已完成
4 期
A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational ProgrammeWeight GainNCT00191828Eli Lilly and Company60
已完成
4 期
Managing Acute Schizophrenia, a Comparison Between Two Atypical AntipsychoticsSchizophreniaNCT00485498Eli Lilly and Company122
已完成
4 期
Olanzapine vs. Low-dose Olanzapine Plus TrifluoperazineSchizophreniaNCT02704962Kaohsiung Kai-Suan Psychiatric Hospital94